Second-line anti-tuberculosis drug concentrations for susceptibility testing in the MODS assay

Fitzwater, SP; Sechler, GA; Jave, O; Coronel, J; Mendoza, A; Gilman, RH; Friedland, JS; Moore, DAJ; (2013) Second-line anti-tuberculosis drug concentrations for susceptibility testing in the MODS assay. The European respiratory journal, 41 (5). pp. 1163-1171. ISSN 0903-1936 DOI:

Full text not available from this repository. (Request a copy)


Multidrug-resistant tuberculosis (TB) threatens TB control worldwide. The microscopic observation drug susceptibility (MODS) assay is a low-cost, high-performance TB diagnostic tool for rapid liquid culture and direct isoniazid and rifampicin drug susceptibility testing (DST). The objective of this study was to explore the potential for extending the MODS assay to rapid second-line DST and to identify critical concentrations of candidate drugs for prospective testing. Sputum samples from 94 TB culture-positive patients receiving second-line TB agents were cultured following standardised MODS protocols, with a range of titrations of antimicrobial drugs added. Critical concentrations were determined using a modified Kaplan-Meier survival curve analysis. Candidate critical concentrations were determined for capreomycin (10 mu g.mL(-1)), ciprofloxacin (1.25 mu g.mL(-1)), cycloserine (40 mu g.mL(-1)), ethambutol (10 mu g.mL(-1)), ethionamide (5 mu g.mL(-1)), kanamycin (5 mu g.mL(-1)) para-aminosalicylic acid (10 mu g.mL(-1)) and streptomycin (10 mu g.mL(-1)). No cut-off point was identified for the other second-line drugs or for pyrazinamide. At particular concentrations of some second-line TB drugs this novel Kaplan-Meier analysis clearly differentiated populations that were susceptible or resistant. These candidate critical concentrations should now be tested in a range of epidemiological settings to define the performance of direct, second-line TB DST with MODS, offering potential low-cost second-line TB DST capacity.

Item Type: Article
Faculty and Department: Faculty of Infectious and Tropical Diseases > Dept of Clinical Research
Research Centre: TB Centre
PubMed ID: 22903960
Web of Science ID: 318750300026


Download activity - last 12 months
Downloads since deposit
Accesses by country - last 12 months
Accesses by referrer - last 12 months
Impact and interest
Additional statistics for this record are available via IRStats2

Actions (login required)

Edit Item Edit Item